HomeCSURE • TLV
add
Cannassure Therapeutics Ltd
Previous close
ILA 1,331.00
Year range
ILA 291.00 - ILA 1,327.00
Market cap
30.05M ILS
Avg Volume
2.80K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
(ILS) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 231.00K | -97.24% |
Operating expense | 45.50K | -96.55% |
Net income | -614.50K | 34.10% |
Net profit margin | -266.02 | -2,292.27% |
Earnings per share | — | — |
EBITDA | -117.50K | -120.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(ILS) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.00K | -95.40% |
Total assets | 657.00K | -98.38% |
Total liabilities | 3.69M | -91.22% |
Total equity | -3.03M | — |
Shares outstanding | 828.21K | — |
Price to book | -3.64 | — |
Return on assets | -44.71% | — |
Return on capital | 11.35% | — |
Cash Flow
Net change in cash
(ILS) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -614.50K | 34.10% |
Cash from operations | 12.50K | 101.90% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -24.50K | -120.85% |
Net change in cash | -12.00K | 98.45% |
Free cash flow | -56.75K | -109.92% |
About
Founded
2016
Website
Employees
72